New Key Statistics Module, Z-Score and F-Score
SHSE:600211 Key Ratios
Market Cap ¥ M | 10,694.55 |
Enterprise Value ¥ M | 8,432.80 |
P/E(ttm) | 13.19 |
PE Ratio without NRI | 8.98 |
Forward PE Ratio | -- |
Price/Book | 2.92 |
Price/Sales | 3.65 |
Price/Free Cash Flow | 9.75 |
Price/Owner Earnings | 16.05 |
Payout Ratio % | 0.41 |
Revenue (TTM) ¥ M | 2,931.00 |
EPS (TTM) ¥ | 2.52 |
Beneish M-Score | -2.96 |
10-y EBITDA Growth Rate % | 26.40 |
5-y EBITDA Growth Rate % | 15.00 |
y-y EBITDA Growth Rate % | 48.70 |
EV-to-EBIT | 9.17 |
EV-to-EBITDA | 9.17 |
PEG | 0.60 |
Shares Outstanding M | 322.32 |
Net Margin (%) | 27.65 |
Operating Margin % | 42.08 |
Pre-tax Margin (%) | 30.99 |
Quick Ratio | 2.79 |
Current Ratio | 2.87 |
ROA % (ttm) | 16.96 |
ROE % (ttm) | 23.52 |
ROIC % (ttm) | 57.35 |
Dividend Yield % | 4.98 |
Altman Z-Score | 6.95 |
SHSE:600211 Number of Guru Trades
SHSE:600211 Volume of Guru Trades
Gurus Latest Trades with SHSE:600211
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600211 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tibet Rhodiola Pharmaceutical Holding Co Insider Transactions
No Available Data